The distribution of propranolol between blood and plasma in hypertensive patients.
R. Sawchuk,J. Robayo,K. Miller
DOI: https://doi.org/10.1111/J.1365-2125.1974.TB00284.X
1974-10-01
British Journal of Clinical Pharmacology
Abstract:CHASE, T.N. (1973). Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists. Arch. NeuroL, 29, 349-35 3. CORRODI, H., FARNEBO, L.O., FUXE, K., HAMBERGER, B. & UNGERSTEDT, U. (1972). ET 495 and brain catecholamine mechanisms: Evidence for stimulation of dopamine receptors. Eur. J. Pharmac., 20, 195-204. CRISTOL, R. (1969). Clinical trial of a new treatment for arteritis of the lower limbs. Progres. Med., 97, 189-198. LINQUETTE, M. & FOURLINNIE, J.C. (1970). Clinical study of a new treatment for trophic conditions of the lower limbs of arteritic origin. Lille Med. Actual., 15, 444-6. MASSEY, V., KOMAI, H. & PALMER, G. (1970). On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazalo (3,4-d) pyrimidines. J. BioL Chem., 215, 2837-2844. McMAHON, F.G. (1970). Uricosurics and xanthine oxidase inhibitors.. A single dose assay. Curr. Ther. Res, 12,414-417. ROYER, R.J., DEBRY, G. & ANDRE, M' (1969). Diabetic arteriopathy. Le Diabete, 1, 25-58.